These restrictions with the BTNX NTS are very pertinent, as we observed e.g. etodesnitazene to possess a similar in vitro potency and efficacy as fentanyl [seven, thirteen] and as it may likely give PWUD a Bogus perception of safety. Moreover, the detectability of nitazene analogues in drug samples could be impacted by solubility issues, as highlig